These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37632762)

  • 21. Liquid chromatography-tandem mass spectrometry screening method using information-dependent acquisition of enhanced product ion mass spectra for synthetic cannabinoids including metabolites in urine.
    Staeheli SN; Veloso VP; Bovens M; Bissig C; Kraemer T; Poetzsch M
    Drug Test Anal; 2019 Sep; 11(9):1369-1376. PubMed ID: 31219237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of the recently emerged synthetic cannabinoid 5F-MDMB-PICA in 'legal high' products and human urine samples.
    Mogler L; Franz F; Rentsch D; Angerer V; Weinfurtner G; Longworth M; Banister SD; Kassiou M; Moosmann B; Auwärter V
    Drug Test Anal; 2018 Jan; 10(1):196-205. PubMed ID: 28371476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The synthetic cannabinoid 5F-MDMB-PICA: A case series.
    Kleis J; Germerott T; Halter S; Héroux V; Roehrich J; Schwarz CS; Hess C
    Forensic Sci Int; 2020 Sep; 314():110410. PubMed ID: 32683270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Validated Method for the Screening of 320 Forensically Significant Compounds in Blood by LC/QTOF, with Simultaneous Quantification of Selected Compounds.
    Partridge E; Trobbiani S; Stockham P; Scott T; Kostakis C
    J Anal Toxicol; 2018 May; 42(4):220-231. PubMed ID: 29329431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brorphine-Investigation and quantitation of a new potent synthetic opioid in forensic toxicology casework using liquid chromatography-mass spectrometry.
    Krotulski AJ; Papsun DM; Noble C; Kacinko SL; Logan BK
    J Forensic Sci; 2021 Mar; 66(2):664-676. PubMed ID: 33201526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantification of new psychoactive substances in Australian wastewater utilising direct injection liquid chromatography coupled to tandem mass spectrometry.
    Bade R; Eaglesham G; Shimko KM; Mueller J
    Talanta; 2023 Jan; 251():123767. PubMed ID: 35973252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection and quantitation of synthetic cannabinoid receptor agonists in infused papers from prisons in a constantly evolving illicit market.
    Norman C; Walker G; McKirdy B; McDonald C; Fletcher D; Antonides LH; Sutcliffe OB; Nic Daéid N; McKenzie C
    Drug Test Anal; 2020 Apr; 12(4):538-554. PubMed ID: 31944624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Profiling of synthesis-related impurities of the synthetic cannabinoid Cumyl-5F-PINACA in seized samples of e-liquids via multivariate analysis of UHPLC-MS
    Münster-Müller S; Matzenbach I; Knepper T; Zimmermann R; Pütz M
    Drug Test Anal; 2020 Jan; 12(1):119-126. PubMed ID: 31307120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a thermal degradation product of CUMYL-PEGACLONE and its detection in biological samples.
    Nash C; Glowacki L; Gerostamoulos D; Pigou P; Scott T; Kostakis C
    Drug Test Anal; 2019 Oct; 11(10):1480-1485. PubMed ID: 31479592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of Eight Synthetic Cannabinoids, Including 5F-AKB48 in Seized Herbal Products Using DART-TOF-MS and LC-QTOF-MS as Nontargeted Screening Methods.
    Moore KN; Garvin D; Thomas BF; Grabenauer M
    J Forensic Sci; 2017 Sep; 62(5):1151-1158. PubMed ID: 28597943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. General unknown screening in hair by liquid chromatography-hybrid quadrupole time-of-flight mass spectrometry (LC-QTOF-MS).
    Broecker S; Herre S; Pragst F
    Forensic Sci Int; 2012 May; 218(1-3):68-81. PubMed ID: 22036310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening procedure for 38 fentanyl analogues and five other new opioids in whole blood by liquid chromatography-tandem mass spectrometry.
    Adamowicz P; Bakhmut Z; Mikolajczyk A
    J Appl Toxicol; 2020 Aug; 40(8):1033-1046. PubMed ID: 32103530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of a validated UHPLC-MS/MS method for 28 fentanyl-analogue and novel synthetic opioids in whole blood in authentic forensic cases.
    Qin N; Xiang P; Shen B; Zhuo X; Shi Y; Song F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Aug; 1124():82-99. PubMed ID: 31177051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suspect and non-target screening workflows to investigate the in vitro and in vivo metabolism of the synthetic cannabinoid 5Cl-THJ-018.
    Vervliet P; Mortelé O; Gys C; Degreef M; Lanckmans K; Maudens K; Covaci A; van Nuijs ALN; Lai FY
    Drug Test Anal; 2019 Mar; 11(3):479-491. PubMed ID: 30242979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening of 104 New Psychoactive Substances (NPS) and Other Drugs of Abuse in Oral Fluid by LC-MS-MS.
    da Cunha KF; Oliveira KD; Huestis MA; Costa JL
    J Anal Toxicol; 2020 Oct; 44(7):697-707. PubMed ID: 32685960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LC-MS/MS quantitation of phytocannabinoids and their metabolites in biological matrices.
    Abd-Elsalam WH; Alsherbiny MA; Kung JY; Pate DW; Löbenberg R
    Talanta; 2019 Nov; 204():846-867. PubMed ID: 31357374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous detection of 93 synthetic cannabinoids by liquid chromatography-tandem mass spectrometry and retrospective application to real forensic samples.
    Hess C; Murach J; Krueger L; Scharrenbroch L; Unger M; Madea B; Sydow K
    Drug Test Anal; 2017 May; 9(5):721-733. PubMed ID: 27400642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergence of Cumyl-PEGACLONE-related fatalities in the Northern Territory of Australia.
    Tiemensma M; Rutherford JD; Scott T; Karch S
    Forensic Sci Med Pathol; 2021 Mar; 17(1):3-9. PubMed ID: 33185835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of new legislation in Germany on prevalence and harm of synthetic cannabinoids.
    Sommer MJ; Halter S; Angerer V; Auwärter V; Eyer F; Liebetrau G; Ebbecke M; Hermanns-Clausen M
    Clin Toxicol (Phila); 2022 Oct; 60(10):1130-1138. PubMed ID: 36074033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nontargeted SWATH acquisition for identifying 47 synthetic cannabinoid metabolites in human urine by liquid chromatography-high-resolution tandem mass spectrometry.
    Scheidweiler KB; Jarvis MJ; Huestis MA
    Anal Bioanal Chem; 2015 Jan; 407(3):883-97. PubMed ID: 25224637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.